F.P.M.J. van Bree

Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51

G. J. Bouma, P.M.W. van der Meer-Prins, F.P.M.J. van Bree et al. · Human Immunology · 1992 · 60 citations

Europium Labeling, Lymphoid Neoplasia, Medicine +12

DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLs IN VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506

Dave L. Roelen, F.P.M.J. van Bree, Urs Schanz et al. · Transplantation · 1993 · 37 citations

Histocompatibility, Immunology, Pathology +19

IgG ANTIBODIES AGAINST AN HLA ANTIGEN ARE ASSOCIATED WITH ACTIVATED CYTOTOXIC T CELLS AGAINST THIS ANTIGEN, IgM ARE NOT

Dave L. Roelen, F.P.M.J. van Bree, Marian D. Witvliet et al. · Transplantation · 1994 · 35 citations

Histocompatibility, Hla, Hla Immunogenetics +20

NO EVIDENCE OF AN INFLUENCE OF THE NONINHERITED MATERNAL HLA ANTIGENS ON THE ALLOREACTIVE T CELL REPERTOIRE IN HEALTHY INDIVIDUALS

Dave L. Roelen, F.P.M.J. van Bree, E. van Beelen et al. · Transplantation · 1995 · 25 citations

Trial and Error in Producing Ankylosing-Spondyhtis-Selective Antisera According to Andrew Geczy

C. J. Beukelman, H. C. Quarles van Ufford, F.P.M.J. van Bree et al. · Scandinavian Journal of Rheumatology · 1990 · 10 citations

Rheumatology, E. Coli, Antimicrobial Susceptibility +15